alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 97.27-5 Master's and officer's responsibility. ( a ) Nothing in this part shall exonerate any master or officer in command from the consequences of any neglect to keep a proper lookout or to maintain a proper fire watch or from any neglect of any precaution which may be required by the ordinary practice of seamen or by the special circumstances of the case. When circumstances require it, additional watches shall be maintained to guard against fire or other danger and to give an alarm in case of accident or disaster.
§ 1111.1 Pre-filing procedures in stand-alone cost cases. ( a ) *General.* At least 70 days prior to the proposed filing of a complaint challenging the reasonableness of a rail rate based on stand-alone cost, complainant shall file a notice with the Board. The notice shall: ( 1 ) Identify the rate to be challenged;
( 2 ) Identify the origin/destination pair(s) to be challenged;
( 3 ) Identify the affected commodities; and
( 4 ) Include a motion for protective order as set forth at 49 CFR 1104.14(c).
( b ) *Liaison.* Within 10 days of the filing of the pre-filing notice, the Board shall appoint a liaison to the parties.
**Exhibit 31.2****CERTIFICATIONS**I, Linda J. Miles, certify that:     1) I have reviewed this quarterly report on Form 10-Q of Bank of Commerce Holdings (the“registrant”);     2) Based on my knowledge, this quarterly report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statements made, in light ofthe circumstances under which such statements were made, not misleading with respect to the periodcovered by this annual report;     3) Based on my knowledge, the financial statements, and other financial information includedin this quarterly report, fairly present in all material respects the financial condition, resultsof operations and cash flows of the registrant as of, and for, the periods presented in thisquarterly report;     4) The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and we have:a. Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervisions, to ensure that material information relating tothe registrant, including its consolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this quarterly report is being prepared;b. Evaluated the effectiveness of the issuer’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controls andprocedures as of the end of the period covered by this report based on such evaluation; andc. Disclosed in this report any change in the issuer’s internal control over financial reportingthat occurred during the issuer’s most recent fiscal quarter (the issuer’s fourth fiscal quarter inthe case of an annual report) that has materially affected, or is reasonably likely to materiallyaffect, the issuer’s internal control over financial reporting; and;5. The issuer’s other certifying officer(s) and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the issuer’s auditors and the auditcommittee of issuer’s board of directors (or persons performing the equivalent functions):a. All significant deficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adversely affect the issuer’sability to record, process, summarize and report financial information; andb. Any fraud, whether or not material, that involves management or other employees who have asignificant role in the issuer’s internal control over financial reporting./s/ LINDA J. MILESLinda J. Miles
[Federal Register Volume 72, Number 115 (Friday, June 15, 2007)]
[Notices]
[Pages 33238-33239]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-2973]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Mental Health; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure f which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Mental Health Special 
Emphasis Panel; Autism Centers Review.
    Date: July 10, 2007.
    Time: 1:30 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Vinod Charles, PhD, Scientific Review 
Administrator, Division of Extramural Activities, National Institute 
of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., 
Room 6151, MSC 9606, Bethesda, MD 20892-9606, 301-443-1606.


[[Page 33239]]


    Name of Committee: National Institute of Mental Health Special 
Emphasis Panel; Disaster Mental Health Centers Review.
    Date: July 26, 2007.
    Time: 10 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Marina Broitman, PhD, Scientific Review 
Administrator, Division of Extramural Activities, National Institute 
of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., 
Room 6153, MSC 9608, Bethesda, MD 20892-9608, 301-402-8152, 
<a href="/cdn-cgi/l/email-protection#38555a4a57514c5559785559515416565150165f574e"><span class="__cf_email__" data-cfemail="630e01110c0a170e02230e020a0f4d0d0a0b4d040c15">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.242, 
Mental Health Research Grants; 93.821, Scientist Development Award, 
Scientist Development Award for Clinicians, and Research Scientist 
Award; 93.282, Mental Health National Research Service Awards for 
Research Training, National Institutes of Health, HHS)

    Dated: June 7, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-2973 Filed 6-14-07; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
§ 1017.6 Result if employee fails to meet deadlines. An employee will not be granted a hearing and will have his/her disposable pay offset in accordance with the Board's offset schedule if the employee: ( a ) Fails to file a petition for a hearing in conformity with the requirements of § 1017.4(b)(8) or § 1017.4(c)(9) of this part, whichever is applicable. However, failure to file within the requisite time period set out in § 1017.4(b)(8) or § 1017.4(c)(9) of this part whichever is applicable, will not result in denial of a hearing or in immediate offset, if the Administrative Law Judge excuses the late filing if the employee can show that the delay was because of circumstances beyond his/her control or because of failure to receive notice of the filing deadline.
( b ) Is scheduled to appear and fails to appear at the hearing without good cause.
#### § 31.40-1 Application—T/ALL

The provisions of this subpart shall apply to all tankships on an international voyage. (See § 30.01-6 of this chapter.)

[CGD 95-012, 60 FR 48049, Sept. 18, 1995, as amended by USCG-1999-4976, 65 FR 6500, Feb. 9, 2000]
EXHIBIT 23.1

                       CONSENT OF INDEPENDENT ACCOUNTANTS



The Board of Directors
Copley Pharmaceutical, Inc.


We consent  to  incorporation  by  reference  in  registration  statements  (No.
33-54707),   (No.   33-96122)   and  (No.   33-96118)  on  Form  S-8  of  Copley
Pharmaceutical,  Inc.  of our report  dated  January 29,  1997,  relating to the
consolidated balance sheets of Copley  Pharmaceutical,  Inc. and subsidiaries as
of  December  31,  1996 and  1995 and the  related  consolidated  statements  of
operations, shareholders' equity and cash flows for the years ended December 31,
1996 and 1995,  which report  appears in the December 31, 1996 annual  report on
Form 10-K of Copley Pharmaceutical, Inc.



/s/ KPMG Peat Marwick LLP

Boston, Massachusetts
March 27, 1997
#### The People of the State of New York ex rel. The Astoria Light, Heat and Power Company, Appellant, *v.*Charles H. Gaus, as Comptroller of the State of New York, Respondent.

*People ex rel. Astoria, Light, H. & P. Co.*v. *Gaus,*137 App. Div. 934, affirmed.

(Argued June 2, 1910;

decided June 14, 1910.)

Appeal from an order of the Appellate Division of' the Supreme Court in the third judicial department, entered January 4, 1910, which confirmed a determination of the defendant in assessing a franchise tax against the relator for the year 1907.

*John A. Gar ver*for appellant.

*Edward R. O’Malley, Attorney-General (Edward JJ. Letehworth*of counsel), for respondent.

Order affirmed, without costs, on opinion in *People ex rel. Westchester Lighting Co.*v. *Gaus*(199 N. Y. 147).

Concur : Cullen, Ch. J., Gray, Haight, Vann, Werner, Hiscook and Chase, JJ.
Exhibit 32.1

** **

** **

**Certification of CEO andCFO**

**Pursuant to 18 U.S.C.Section 1350,**

**AsAdopted Pursuant to**

Section 906 of the Sarbanes-Oxley Act of2002

 

 

 

In connection with theQuarterly Report on Form 10-Q of Real Estate Associates Limited V (the"Partnership"), for the quarterly period ended September 30, 2009 as filed withthe Securities and Exchange Commission on the date hereof (the "Report"), StevenD. Cordes, as the equivalent of the chief executive officer of the Partnership,and Stephen B. Waters, as the equivalent of the chief financial officer of thePartnership, each hereby certifies, pursuant to 18 U.S.C. Section 1350, asadopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to thebest of his knowledge:

 

(1)   The Reportfully complies with the requirements of Section 13(a) or 15(d) of the SecuritiesExchange Act of 1934; and

 

(2)   Theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Partnership.

 

 

This certification isfurnished with this Report pursuant to Section 906 of the Sarbanes-Oxley Act of2002 and shall not be deemed filed by the Partnership for purposes of Section 18of the Securities Exchange Act of 1934, asamended.
, '

IEo Stq,,,

S UNITED STATES ENVIRONMENTAL PROTECTION AGENCY WASHINGTON, D.C. 20460
0

~~ Tq t PROt- G

~ \



### SEP 2 9 i014 OFFICE OF AIR AND RADIATION



### Mr. Jose R. Franco Carlsbad Field Office LJ.S. Department of Energy P.O. Box 3090 Carlsbad, New Mexico 88221-3090
Dear Mr. Franco: This letter is to inform you that the U.S. Environmental Protection Agency has begun the completeness review of the March 2014 U.S. Department of Energy (DOE) Compliance Recertification Application (CRA-2014) for the Waste Isolation Pilot Plant (WIPP). In accordance with our WIPP Compliance E`riteria (40 CFR Part 194), a full technical evaluation of the recertification shall not begin until the EPA has informed the Secretary of the DOE in writing that the Agency has deemed the recertification application as complete. This is an administrative step to ensure that the application addresses all the required regulatory elements. 'rhe completeness determination does not reflect any conclusion regarding the WIPP's continued compliance with the EPA's radioactive waste disposal regulations (40 CFR Part 191, Subparts B and C) or W I PP Compliance Criteria. A Federal Register notice formally announcing receipt of the CRA-2014 and initiation of the EPA's completeness review will be published in the near future. Please note that our completeness review has been delayed due to the ongoing response to the February 2014 radiological incident at the WIPP. We are considering how the incident may affect our review of the CRA-2414. Although the incident took place after the preparation of the CRA-2014, the DOE has indicated that changes will need to be made to the WIPP disposal system in order to reopen the facility and that the Department will provide supplemental information on the incident and identify potential ramifications on compliance.

Intemet Address (URL) • http://www.epa.gov

Recycled/Recyclable 0 Printed with Vegetable Oil Based Inks on 100% Postconsumer, Process Chlorine Free Recycled Paper1 appreciate the helpful and cooperative interactions with DOE staff to date. We look forward to continued cooperation from your staff as we move forward with our review. If you have any questions concerning our review of the CRA-2014, please contact Kathy Economy at (202) 343-9844 ( cconomy.kathleen@epa.gov ).

D. Edwards
Radiation Protection Division
cc: Electronic Distribution
§ 1572.400 Scope and definitions. ( a ) *Scope.* This part applies to— ( 1 ) States that issue an HME for a commercial driver's license;
( 2 ) Individuals who apply to obtain or renew an HME for a commercial driver's license and must undergo a security threat assessment under 49 CFR part 1572; and
( 3 ) Entities who collect fees from such individuals on behalf of TSA.
( b ) *Terms.* As used in this part:
*Commercial driver's license (CDL)* is used as defined in 49 CFR 383.5.
*FBI Fee* means the fee required for the cost of the Federal Bureau of Investigation (FBI) to process fingerprint records.
*Information Collection Fee* means the fee required, in this part, for the cost of collecting and transmitting fingerprints and other applicant information under 49 CFR part 1572.
*Threat Assessment Fee* means the fee required, in this part, for the cost of TSA adjudicating security threat assessments, appeals, and waivers under 49 CFR part 1572.
*TSA agent* means an entity approved by TSA to collect and transmit fingerprints and applicant information, in accordance with 49 CFR part 1572, and fees in accordance with this part.
[85 FR 16499, Mar. 23, 2020, as amended at 89 FR 35631, May 1, 2024]
COURT OF APPEALS

SECOND DISTRICT OF TEXAS

FORT WORTH

NO. 02-13-00467-CR

DWANA CONNER A/K/A SWANNA 

CONNER

APPELLANT

V.

THE STATE OF TEXAS STATE

----------

FROM THE 297TH DISTRICT COURT OF TARRANT COUNTY

------------

MEMORANDUM OPINION1 AND JUDGMENT

----------

We have considered “Appellant’s Motion To Withdraw Appeal.” The 

motion complies with rule 42.2(a) of the rules of appellate procedure. Tex. R. 

App. P. 42.2(a). No decision of this court having been delivered before we 

received this motion, we grant the motion and dismiss the appeal. See Tex. R. 

App. P. 42.2(a), 43.2(f).

 

1See Tex. R. App. P. 47.4.
2

PER CURIAM

PANEL: MCCOY, MEIER, and GABRIEL, JJ.

DO NOT PUBLISH

Tex. R. App. P. 47.2(b)

DELIVERED: October 31, 2013
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM AVONDALE
INDUSTRIES, INC.'S ANNUAL REPORT FILED ON FORM 10-K FOR THE YEAR ENDED DECEMBER
31, 1996 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                          48,944
<SECURITIES>                                         0
<RECEIVABLES>                                  119,139
<ALLOWANCES>                                         0
<INVENTORY>                                     21,785
<CURRENT-ASSETS>                               222,490
<PP&E>                                         254,611
<DEPRECIATION>                               (127,009)
<TOTAL-ASSETS>                                 362,872
<CURRENT-LIABILITIES>                          103,015
<BONDS>                                         54,866
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        15,927
<OTHER-SE>                                     165,926
<TOTAL-LIABILITY-AND-EQUITY>                   362,872
<SALES>                                        624,929
<TOTAL-REVENUES>                               624,929
<CGS>                                          543,102
<TOTAL-COSTS>                                  543,102
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               4,986
<INCOME-PRETAX>                                 34,495
<INCOME-TAX>                                     3,700
<INCOME-CONTINUING>                             30,795
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    30,795
<EPS-PRIMARY>                                     2.13
<EPS-DILUTED>                                     2.13
        

</TABLE>
"MS. KALUHIWA: Aloha mai kakou. My name I am the Oahu representative of

the Aha Moku Committee, a committee comprised of

other Hawaiian practitioners. I wish to inform you

that we practitioners are deeply concerned that

this proposed Administrative Order of Consent may

go forward unamended. I wish to offer our

agreement with Mahealani Cypher and the Oahu

Council of Hawaiian Civic Club's testimony as our

own. Mahalo.

(Applause.)

"
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Human Genome Research Institute Special Emphasis Panel, GWA Phenotype and Exposure Measures.                    

*Date:*                         July 19, 2007.                    

*Time:*                         12 p.m. to 1:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 5635 Fishers Lane, Suite 4076, Bethesda, MD 20892 (Telephone Conference Call).                    

*Contact Person:*                         Ken D. Nakamura, PhD, Scientific Review Administrator, Scientific Review Branch, National Human Genome Research Institute, National Institutes of Health, 5635 Fishers Lane, Suite 4076, MSC 9306, Rockville, MD 20852, 301-402-0838, nakamurk@mail.nih.gov.                    

This note is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS)

Dated: July 6, 2007.

Jennifer Spaeth, 

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 07-3397 Filed 7-11-07; 8:45 am]

BILLING CODE 4140-01-M
EXHIBIT 32.1
                                                                    ------------

      CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

                                   PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



Each of the undersigned hereby certifies that this Annual Report on Form 10-KSB
complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended, and the information contained in such report
fairly represents, in all material respects, the financial condition and results
of operations of the Company.

December 30, 2003

/s/CHARLES SHEFFIELD
Charles Sheffield
President and Chief Executive Officer

/s/ E.A. BUCHHOLTZ
E.A. Buchholtz
Chief Financial Officer